Hereditary Diseases are diseases or disorders in which susceptibility or causation is transmitted through genetic material from biological parents to offspring. The term is commonly used for conditions with an inherited genetic basis, although the degree to which inheritance determines disease can vary considerably. Some hereditary diseases result from a pathogenic variant in a single gene, while others involve multiple genes interacting with environmental and lifestyle factors. Inherited conditions may be present from birth or may first become clinically apparent decades later. Hereditary therefore describes a mode of transmission or familial genetic origin, not necessarily the age at which symptoms begin or the severity of disease.
The mechanisms of hereditary disease depend on the underlying inheritance pattern. Autosomal dominant conditions can occur when one altered copy of a relevant gene is sufficient to cause disease, while autosomal recessive conditions generally require pathogenic variants affecting both copies. X-linked inheritance involves genes on the X chromosome and can produce different patterns in males and females. Mitochondrial inheritance follows transmission of mitochondrial DNA primarily through the maternal line. Some conditions involve more complex inheritance, including polygenic susceptibility, genomic imprinting, anticipation, mitochondrial heteroplasmy or variable penetrance. Recognising the pattern can help clinicians estimate recurrence risks within a family.
Penetrance and expressivity are important concepts in hereditary disease. Penetrance describes the proportion of people carrying a disease-associated genetic variant who develop the associated phenotype, whereas expressivity describes variation in the nature or severity of manifestations among people with the same or related genetic cause. Consequently, inheriting a pathogenic variant does not always mean that disease will develop in an identical form or at the same age. Environmental exposure, modifier genes, epigenetic mechanisms and chance can contribute to phenotypic variation. These concepts explain why family members with apparently similar genetic findings may have substantially different clinical experiences.
Examples of hereditary diseases include familial hypercholesterolaemia, cystic fibrosis, sickle cell disease, Huntington disease and many inherited forms of retinal, neurological, metabolic and connective-tissue disease. Their mechanisms differ substantially. Familial hypercholesterolaemia can involve impaired clearance of low-density lipoprotein cholesterol; cystic fibrosis results from pathogenic variants in the CFTR gene affecting epithelial ion transport; sickle cell disease results from particular variants affecting haemoglobin; Huntington disease is associated with a CAG repeat expansion in the HTT gene. These examples demonstrate that “hereditary disease” encompasses conditions with very different molecular mechanisms, clinical courses and treatment strategies.
Hereditary Diseases are not synonymous with congenital disorders. A hereditary condition is related to inherited genetic material, whereas a congenital disorder is present at birth. Some hereditary diseases are congenital, but others manifest later because the pathogenic mechanism requires time, developmental changes or accumulated physiological effects. Conversely, congenital abnormalities can arise from non-genetic developmental disturbances, infections, nutritional deficiencies, medication exposure or other factors and therefore are not necessarily hereditary. Similarly, hereditary disease should not automatically be equated with “genetic disease”, because genetic disease is the broader category that includes conditions caused by inherited variants as well as variants arising de novo or occurring somatically.
Diagnosis of Hereditary Diseases may involve clinical assessment, pedigree analysis, biochemical testing, imaging, molecular genetic testing, chromosome analysis or combinations of these approaches. Testing can range from targeted analysis of a known familial variant to multigene panels, exome sequencing or genome sequencing. The choice depends on the suspected disorder and the clinical question. Genetic counselling can explain possible outcomes, including a pathogenic finding, a benign finding, a variant of uncertain significance or a negative result that does not necessarily exclude a genetic condition. Interpretation requires knowledge of the patient's phenotype and the limitations of the particular test.
Management varies widely and may include preventive surveillance, medication, surgery, dietary treatment, enzyme replacement, targeted molecular therapies, reproductive options and supportive care. Some hereditary diseases have disease-modifying treatments, while others are managed mainly through symptom control and monitoring for complications. Genetic information can also have implications for relatives because identifying a pathogenic variant in one person may make targeted testing relevant to biological family members. Such testing should be undertaken through appropriate clinical pathways because genetic findings can have medical, psychological, reproductive and familial implications.
A common misconception is that hereditary means inevitable. Many inherited variants increase risk rather than guaranteeing disease, while some pathogenic variants do have highly penetrant effects. Another misconception is that hereditary diseases cannot be treated; although the underlying DNA sequence may not currently be reversible in many conditions, treatment can prevent complications, replace missing biological functions or directly target molecular mechanisms. The term therefore describes aetiology or inheritance rather than prognosis. Accurate understanding requires identifying the specific condition, genetic mechanism, inheritance pattern, penetrance and available evidence rather than making assumptions from the word “hereditary” alone.
